Molecular Medicine Reports Molecular Medicine Reports 1791-2997 1791-3004 D.A. Spandidos 10.3892/mmr.2017.7440 mmr-16-05-6506 Articles MicroRNA-21 increases cell viability and suppresses cellular apoptosis in non-small cell lung cancer by regulating the PI3K/Akt signaling pathway WangTao 1 * CaiZhenyu 2 * HongGuolin 1 ZhengGangsen 1 HuangYu 1 ZhangShun 3 DaiJinhua 4 Department of Clinical Laboratory, The First Affiliated Hospital of Xiamen University, Fujian Medical University, Xiamen, Fujian 361003, P.R. China Department of Anesthesiology, The First Affiliated Hospital of Xiamen University, Fujian Medical University, Xiamen, Fujian 361003, P.R. China Stem Cell and Regenerative Medicine Laboratory, Ningbo No. 2 Hospital, Ningbo, Zhejiang 315010, P.R. China Department of Clinical Laboratory, Ningbo No. 2 Hospital, Ningbo, Zhejiang 315010, P.R. China Correspondence to: Dr Jinhua Dai, Department of Clinical Laboratory, Ningbo No. 2 Hospital, 41 Xibei Street, Ningbo, Zhejiang 315010, P.R. China, E-mail: daijinhua02736@126.com

Contributed equally

 052017 08092017 16 5 6506 6511 25042016 30032017 Copyright: © Wang et al. 2017 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

MicroRNA (miRNA/miR), a type of non-coding RNA molecule, is able to inhibit the expression of target genes at multiple stagess. There are 800–1,000 known miRNAs in the human genome, which serve important roles in cell proliferation, differentiation, apoptosis and migration. Previous studies have demonstrated that the expression of miR-21 is upregulated in numerous types of malignant tumor, and that miR-21 participates in the occurrence and development of tumors via complex regulatory mechanisms. The present study aimed to investigate the association between miR-21 expression, cell viability and apoptosis in a lung cancer cell line, and to elucidate the potential mechanisms. miR-21 or small interfering RNA against miR-21 were transfected into A549 non-small cell lung cancer cells. The mRNA expression of miR-21 was confirmed. Cell viability and apoptosis were examined using MTT and flow cytometric assays, respectively. The expression of certain apoptosis-associated proteins was detected by western blotting. The results of the present study demonstrated that miR-21 was able to increase the proliferation of A549 cells by inhibiting cellular apoptosis. miR-21 inhibited apoptosis by modulating the activation of the phosphatidylinositol 3-kinase/Rac-α serine/threonine protein kinase (Akt) pathway in A549 cells. Correspondingly, inhibition of Akt decreased the apoptosis of A549 cells in miR-21 siRNA-treated cells. Therefore, the results of the present study demonstrated that miR-21 increased cell viability by inhibiting apoptosis, through regulation of Akt activation. The present study demonstrated that miR-21 may be involved in the progression of lung cancer and may be a novel therapeutic target for the disease.

 non-small cell lung cancer microRNA-21 phosphatidylinositol 3-kinase Rac-α serine/threonine protein kinase cellular apoptosis cell proliferation Introduction

Lung cancer is a notable cause of mortality and is the 2nd most common type of cancer worldwide, of which non-small cell lung cancer (NSCLC) accounts for 80–85% of cases (1,2). The majority of patients with NSCLC are diagnosed in an advanced disease stage; therefore, the disease is associated with a poor 5-year survival rate (3). Due to advances in molecular biology, treatments for adenocarcinoma have improved; treatments for lung cancer, however, remain unsatisfactory, and the incidence and mortality rate of patients with lung cancer remain high (4,5).

MicroRNAs (miRNAs/miRs) are small, non-coding RNA molecules which serve important roles as regulatory factors in carcinogenesis (6,7). miRNAs have been reported to be involved in multiple types of tumor, including lung cancer. The discovery of miRNAs may provide a novel and powerful tool for researching the mechanism, diagnosis and treatment of lung cancer. Previous research has characterized miRNAs as a group of novel therapeutic small molecules involved in the treatment and regulation of lung cancer. Abnormal expression of miRNAs in plasma has been observed in some patients with malignant tumors, such as miR-30a, which was demonstrated to be overexpressed in NSCLC cells (8). Chen et al (9) reported that miR-206 is underexpressed in lung cancers and may be a potential target for therapy by inhibiting epithelial-mesenchymal transition and angiogenesis in lung cancer. With the aim of investigating the potential role of miR-95 in the treatment of NSCLC, Ma et al (10) and Chen et al (11) investigated the expression level of miR-95 and observed it to be overexpressed in recurrent NSCLC, and demonstrated that miR-95a is a potential therapeutic target for the treatment of NSCLC.

Metastasis is recognized as a frequent cause of mortality in patients with NSCLC. Previous studies have demonstrated the roles of miR-10b and miR-145 in the invasive and metastatic capabilities of lung cancer cells, and that miR-10b upregulated the migration and invasion of lung cancer cells, while miR-145 suppressed migration and invasion (12–15). These previous results provide a potential approach for developing miRNA-based therapeutic strategies for the treatment of NSCLC. In a correlation study of miR-21 in lung cancer cells, miR-21 was investigated as a potential serum biomarker, and diagnostic and prognostic indicator for NSCLC (16–18). However, the molecular mechanism underlying the role of miR-21 in lung cancer remains to be elucidated.

The objective of the present study was to investigate the association between miR-21 expression, cell viability and apoptosis in lung cancer. The results of the present study demonstrated that miR-21 was able to increase the viability of A549 cells by inhibiting cellular apoptosis. In addition, the signaling pathway of miR-21 in the regulation of lung cancer cell lines was investigated, and the results demonstrated that miR-21 inhibited cellular apoptosis by modulating the activation of the phosphatidylinositol 3-kinase (PI3K)/Rac-α serine/threonine protein kinase (Akt) pathway in A549 cells. Correspondingly, inhibition of Akt using MK-2206 decreased the rate of apoptosis in miR-21 knockdown A549 cells. The results of the present study may provide a theoretical basis for, and novel insights into, the treatment of lung cancer.

 Materials and methods <sec> <title>Cell culture and transfection

A549 cells were purchased from the American Type Culture Collection (Manassas, VA, USA). Cells were cultured in Dulbecco's modified Eagle's medium (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (Invitrogen; Thermo Fisher Scientific, Inc.) at 37°C in a humidified atmosphere with 5% CO2. The cells were transfected with miR-21 (Lipo miR-21 group), small interfering (si)RNA against miR-21 (5′-UCAACAUCAGUCUGAUAAGCUA-3′) or mismatch siRNA as a negative control (5′-UCUUCAUGAGUCAGAUUACCUA-3′). All transfections were performed by using Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc.), according to the manufacturer's protocol. Additionally, after transfection for 48 h, certain cells that were transfected with miR-21 siRNA were treated with the Akt inhibitor MK-2206 at room temperature for 24 h (20 µM; Selleck Chemicals, Houston, TX, USA).

 Cell viability assay

For transfection, cells were cultured on 12-well plates and seeded at a density of 5×104 cells/well for 48 h at 37°C. The cells were harvested using trypsin, re-suspended in 3 ml culture medium, and counted with a hemocytometer. Cell samples were collected at 0, 24 and 48 h after transfection for further analysis. For the MTT assays, transfected cells at a density of 5×103 cells/well were seeded onto 96-well culture plates. After 24 h incubation at 37°C, cell viability was assayed by adding 10% MTT (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) to 0.2 ml culture medium and incubating at 37°C for 3 h. Following removal of the medium, formazan crystals were dissolved with 100 µl dimethyl sulfoxide (Sigma-Aldrich; Merck KGaA) for 10 min at room temperature, and the optical density was measured at 590 nm with a Multiskan EX (Thermo Fisher Scientific, Inc.). The assay was repeated 3 times (19).

 Cell cycle analysis using flow cytometry

Cells were harvested by trypsinization and washed with PBS. The cells were fixed with 100% ice-cold methanol at −20°C overnight. The cells were subsequently incubated for 30 min in 50 µg/ml propidium iodide with 1 mg/ml RNase. The apoptotic cells were observed at 450 nm excitation wavelength by using a FACScan flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA). Data were analyzed using CellQuest 3.1f software (BD Biosciences). Each condition was repeated ≥3 times (20).

 RNA extraction and the reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

Total RNA was extracted using TRIzol (Invitrogen; Thermo Fisher Scientific, Inc.) and reverse transcribed using an RT kit (Toyobo Co., Ltd., Osaka, Japan). miRNAs were extracted using the All-in-One miRNA RT kit (GeneCopoeia, Inc., Rockville, MD, USA). cDNA was subjected to qPCR using SYBR Premix Ex Taq (Takara Biotechnology Co., Ltd., Dalian, Japan) using StepOnePlus (Invitrogen; Thermo Fisher Scientific, Inc.). qPCR conditions were as follows: Initial denaturation at 95°C for 15 sec; 30 cycles of denaturation at 95°C for 30 sec, annealing at 61°C for 5 sec and extension at 72°C for 15 sec; final extension at 72°C for 10 min. miR-21 expression was normalized to U6 using the 2−ΔΔCq method (21). Primers for miR-21 and U6 were purchased from GeneCopoeia, Inc. U6 primers: forward, 5′-CTTCGGCAGCACATATACT-3′; and reverse, 5′-AAAATATGGAACGCTTCACG-3′. miR-21 primers: forward, 5′-ACGTTGTGTAGCTTATCAGACTG-3′; and reverse, 5′-AATGGTTGTTCTCCACACTCTC-3′.

 Western blot analysis

Cells were washed with PBS and lysed in a lysis buffer [pH 7.4; 20 mM Tris-HCl, 0.1 mM EDTA, 0.1% SDS, 20 mM NaF, 150 mM NaCl, 0.1% Triton X-100, 1% NP-40, 1 mM Na3VO4 and 1X protease inhibitor (Roche Diagnostics, Basel, Switzerland)]. The proteins were quantified using the BCA Protein assay kit (Pierce; Thermo Fisher Scientific, Inc.). Protein samples (30 µg per lane) were separated using 10–12% SDS-PAGE and transferred to a nitrocellulose membrane (Whatman; GE Healthcare Life Sciences, Little Chalfont, UK) following boiling for 10 min in SDS sample buffer (Sigma-Aldrich; Merck KGaA). Following blocking with 5% skimmed milk in TBS with Tween-20 (TBS-T) for 1 h at room temperature, the membranes were incubated with primary antibodies against phosphorylated (p)-Akt (cat. no. 4060; 1:1,000; Cell Signaling Technology, Inc., Danvers, MA, USA), Akt (cat. no. 9272; 1:1,000; Cell Signaling Technology, Inc.), B-cell lymphoma 2 (Bcl-2; cat. no. ab32124; 1:1,000; Abcam, Cambridge, UK), Bcl-2-associated X (BAX; cat. no. ab32503; 1:1,000; Abcam), procaspase-3 (cat. no. ab32150; 1:1,000; Abcam), active caspase-3 (cat. no. ab2302; 1:1,000; Abcam) and actin (cat. no. ab8227; 1:1,000; Abcam) overnight at 4°C. Membranes were washed with TBS-T and incubated with horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (cat. no. ab205718; 1:5,000; Abcam) for 2 h at room temperature. Protein bands were visualized using the WEST-ZOL-plus Western Blot Detection System (22).

 Statistical analysis

Data are presented as the mean ± standard deviation. All statistical analyses were performed using GraphPad Prism 5.0 software (GraphPad Software, Inc., La Jolla, CA, USA). P-values were calculated using one-way analysis of variance. P<0.05 was considered to indicate a statistically significant difference.

 Results <sec> <title>Overexpression of miR-21 increases cell viability in A549 cells

The mRNA expression of miR-21 is presented in Fig. 1A. The results demonstrated that miR-21 expression was significantly upregulated by miR-21 overexpression, but was downregulated by miR-21 suppression, compared with their corresponding controls (P<0.05). An MTT assay was used to determine the viability of A549 cells following 0, 24 and 48 h of transfection with miR-21, mismatch siRNA or miR-21 siRNA. The results presented in Fig. 1B demonstrated that overexpression of miR-21 significantly increased cell viability in A549 cells. However, the result was reversed by suppression of miR-21.

 Overexpression of miR-21 promotes cell proliferation by inhibiting cellular apoptosis

The results of the flow cytometry demonstrated that the apoptotic rates of the A549 cells in the control, miR-21, mismatch siRNA and miR-21 siRNA groups were 9, 5, 8 and 28%, respectively (Fig. 2). The results of the present study demonstrated that the apoptosis rate of A549 cells in the miR-21-treated group significantly decreased compared with the control (P<0.05). However, suppression of miR-21 significantly increased cell apoptosis in A549 cells compared with the mismatch siRNA group (P<0.05).

 miR-21 inhibits apoptosis by modulating the activation of the PI3K/Akt signaling pathway in A549 cells

The apoptosis inhibition mechanism of miR-21 in A549 cells was examined by analyzing the protein expression of associated factors. The western blotting results for p-Akt, Akt, Bcl-2, BAX, procaspase-3, active caspase-3 and actin are presented in Fig. 3. The results demonstrated that overexpression of miR-21 upregulated p-Akt and Bcl-2 expression, and downregulated the expression of BAX and procapase-3, compared with the control group. Suppression of miR-21 demonstrated the opposite effect on these factors. There were no obvious changes in the expression of Akt and active caspase-3 following miR-21 overexpression or suppression. The results of the present study demonstrated that miR-21 inhibited apoptosis in A549 cells by modulating the activation of the PI3K/Akt signaling pathway.

 Inhibition of Akt decreases the rate of apoptosis in A549 cells

The expression of Akt was inhibited and the apoptosis rate of the A549 cells was measured. The miR-21 siRNA + Akt inhibitor cells exhibited a decreased apoptotic rate compared with the miR-21 siRNA group, as presented in Fig. 4. The results demonstrated that the apoptotic rates of the A549 cells in the control, miR-21, mismatch siRNA, miR-21 siRNA and miR-21 siRNA + Akt inhibitor groups were 9, 4.3, 8, 28 and 9.3%, respectively. miR-21 overexpression significantly inhibited cell apoptosis compared with the control group, whereas miR-21 suppression promoted apoptosis as apoptosis was significantly increased compared with the mismatch siRNA group. However, the promoting effect of miR-21 suppression on cell apoptosis was abolished by treatment with an Akt inhibitor, as apoptosis was significantly reduced in the miR-21 siRNA + Akt inhibitor group compared with the miR-21 siRNA-only group. These results indicated that inhibition of Akt decreased the rate of apoptosis in A549 cells when miR-21 was suppressed.

 Discussion

NSCLC is one of the most common types of malignant tumor worldwide (23). It is associated with the highest incidence of morbidity and mortality, and smoking is the primary risk factor (1). A lack of effective detection methods has led to the ineffectiveness of conventional therapy. The prognosis of NSCLC is poor, due to insufficient mechanistic understanding.

As one of the most important regulators of the pathogenesis of human disease through the regulation of gene expression, miRNAs has been reported to serve roles in the progression of human lung cancer, including miR-196a, miR-200c and miR-204 (24–26). miR-21 is one of the miRNAs reported to be associated with apoptosis in human NSCLC cells (17,18). However, more research into the potential role of miR-21 is required. In order to investigate the molecular pathogenesis of NSCLC, and to verify whether miR-21 may be a molecular diagnostic and prognostic marker in NSCLC, the present study sought to investigate the molecular mechanisms in detail.

In the present study, miR-21 was overexpressed in A549 cells and cell viability was assayed following transfection with miR-21, mismatch siRNA or miR-21 siRNA. The results obtained in the MTT assay demonstrated that miR-21 was able to increase the viability of A549 cells. The apoptotic rate of A549 cells was investigated, and it was demonstrated that miR-21 increased viability by inhibiting cellular apoptosis.

The activation of apoptotic pathway serves an important role in biological development and tissue homeostasis (27). Proteins in the Bcl-2 family, including Bcl-binding component 3, BAX and Bcl-2 homologous antagonist/killer, are downregulated by numerous anti-apoptotic miRNAs, which leads to resistance to apoptosis (28). Proteins associated with apoptotic pathways in cancer, including BAX in cervical cancer, caspase 3 in glioblastoma and squamous cell carcinoma, and caspase 9 in glioblastoma, have been studied previously (29,30). In the present study, the association between miR-21 and the PI3K/Akt pathway was investigated in order to elucidate the apoptotic mechanism.

The PI3Ks and Akts consist of multiple isoforms, and the PI3K/Akt signaling pathway is able to regulate cellular processes as diverse as cell growth, survival, proliferation and migration (31,32). Due to the function of signal transmission, PI3K/Akt has been associated with signaling pathways in various types of cancer, including lung cancer (33,34). Expression of p-Akt, Akt, Bcl-2, BAX, procaspase-3, active caspase-3 and actin proteins were measured by western blotting in the present study, in order to observe the underlying mechanism of the regulatory function of miR-21. The western blotting results demonstrated that the inhibition of apoptosis mediated by miR-21 in A549 cells is associated with activation of the PI3K/Akt signaling pathway. The expression of Akt was inhibited and the apoptotic rate was measured. The results of the present study demonstrated that the inhibition of Akt decreased the apoptotic rate of lung cancer cells.

The results of the present study demonstrated that the overexpression of miR-21 increased cell viability in lung cancer cells. In addition, the present study demonstrated the underlying mechanism of apoptosis in lung cancer. The results of the present study suggest that miR-21 may be involved in the progression of lung cancer and may be a novel therapeutic target for the disease, and the present results may provide a novel therapeutic approach to target lung cancer metastasis via the PI3K/Akt signaling pathway. The present study provides a foundation for further studies into the role of miR-21 in lung cancer. Specific aspects of the underlying mechanism require further research.

 Acknowledgements

The present study was supported by the Demonstration Project of Ningbo Science and Technology Service Industry (grant no. 2014F10026).

 References LysovZDwivediDJGouldTJLiawPCProcoagulant effects of lung cancer chemotherapy: Impact on microparticles and cell-free DNABlood Coagul Fibrinolysis287282201710.1097/MBC.000000000000054626919453 SherwoodJLCorcoranCBrownHSharpeADMusilovaMKohlmannAOptimised pre-analytical methods improve KRAS mutation detection in circulating tumour DNA (ctDNA) from patients with non-small cell lung cancer (NSCLC)PLoS One11e0150197201610.1371/journal.pone.0150197269189014769175 TavernaSGiallombardoMGil-BazoICarrecaAPCastigliaMChacárteguiJAraujoAAlessandroRPauwelsPPeetersMRolfoCExosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: Critical analysis of evidence and potential role in clinical practiceOncotarget72874828760201610.18632/oncotarget.7638269192485053760 FerlayJSteliarova-FoucherELortet-TieulentJRossoSCoeberghJWComberHFormanDBrayFCancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012Eur J Cancer4913741403201310.1016/j.ejca.2012.12.02723485231 TianYLiuQHeXYuanXChenYChuQWuKEmerging roles of Nrf2 signal in non-small cell lung cancerJ Hematol Oncol914201610.1186/s13045-016-0311-0269224794769825 YongchunZLinweiTXicaiWLianhuaYGuangqiangZMingYGuanjianLYujieLYunchaoHMicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYBCancer Lett3476574201410.1016/j.canlet.2014.01.01924486218 XieZCaiLLiRZhengJWuHYangXLiHWangZDown-regulation of miR-489 contributes into NSCLC cell invasion through targeting SUZ12Tumour Biol3664976505201510.1007/s13277-015-3340-325833694 SunLChenYSuQTangXLiangYCheGLuoFIncreased plasma miRNA-30a as a biomarker for non-small cell lung cancerMed Sci Monit22647655201610.12659/MSM.897330269182654771099 ChenQYJiaoDMWuYQChenJWangJTangXLMouHHuHZSongJYanJWuLJMiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathwayOncotarget71824718261201610.18632/oncotarget.7570269190964951285 MaWMaCNLiXDZhangYJExamining the effect of gene reduction in miR-95 and enhanced radiosensitivity in non-small cell lung cancerCancer Gene Ther236671201610.1038/cgt.2016.226915403 ChenXChenSHangWHuangHMaHMiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancerBiomed Pharmacother68589595201410.1016/j.biopha.2014.04.00824835695 LiYLiYLiuJFanYLiXDongMLiuHChenJExpression levels of microRNA-145 and microRNA-10b are associated with metastasis in non-small cell lung cancerCancer Biol Ther17272279201610.1080/15384047.2016.1139242269094664847994 XiaWChenQWangJMaoQDongGShiRZhengYXuLJiangFDNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinomaSci Rep516901201510.1038/srep16901265826024652277 ZhangYLinQMicroRNA-145 inhibits migration and invasion by down-regulating FSCN1 in lung cancerInt J Clin Exp Med8879488022015263095314538028 ZhangYYangXWuHZhouWLiuZMicroRNA-145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non-small-cell lung cancer cellsMol Med Rep1261936198201510.3892/mmr.2015.416326238532 ZhaoWZhaoJJZhangLXuQFZhaoYMShiXYXuAGSerum miR-21 level: A potential diagnostic and prognostic biomarker for non-small cell lung cancerInt J Clin Exp Med814759147632015266289584658847 LiXZangAJiaYZhangJFanWFengJDuanMZhangLHuoRJiaoJZhuXTriptolide reduces proliferation and enhances apoptosis of human non-small cell lung cancer cells through PTEN by targeting miR-21Mol Med Rep1327632768201610.3892/mmr.2016.484426847601 TianLShanWZhangYLvXLiXWeiCErratum to: Up-Regulation of miR-21 expression predicate advanced clinicopathological features and poor prognosis in patients with non-small cell lung cancerPathol Oncol Res22439201610.1007/s12253-015-0004-y26613925 LiZLiNWuMLiXLuoZWangXExpression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4Mol Cell Biochem381233242201310.1007/s11010-013-1707-623744532 ZhangNSuYXuLTargeting PKCε by miR-143 regulates cell apoptosis in lung cancerFEBS Lett58736613667201310.1016/j.febslet.2013.09.01824070896 LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) methodMethods25402408200110.1006/meth.2001.126211846609 NamKOhSLeeKMYooSAShinICD44 regulates cell proliferation, migration, and invasion via modulation of c-Src transcription in human breast cancer cellsCell Signal2718821894201510.1016/j.cellsig.2015.05.00225979842 ZhangYZhaoJQiuLZhangPLiJYangDWeiXHanYNieSSunYCo-expression of ILT4/HLA-G in human non-small cell lung cancer correlates with poor prognosis and ILT4-HLA-G interaction activates ERK signalingTumour Biol371118711198201610.1007/s13277-016-5002-526939901 LiQYangZChenMLiuYDownregulation of microRNA-196a enhances the sensitivity of non-small cell lung cancer cells to cisplatin treatmentInt J Mol Med3710671074201610.3892/ijmm.2016.251326936095 JiaoASuiMZhangLSunPGengDZhangWWangXLiJMicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2, an epithelial-mesenchymal transition regulatorMol Med Rep1333493355201610.3892/mmr.2016.490126935975 ZhangSGaoLThakurAShiPLiuFFengJWangTLiangYLiuJJChenMRenHmiRNA-204 suppresses human non-small cell lung cancer by targeting ATF2Tumour Biol371117711186201610.1007/s13277-016-4906-426935060 LindstenTRossAJKingAZongWXRathmellJCShielsHAUlrichEWaymireKGMaharPFrauwirthKThe combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissuesMol Cell613891399200010.1016/S1097-2765(00)00136-2111632123057227 FrixaTDonzelliSBlandinoGOncogenic microRNAs: Key players in malignant transformationCancers (Basel)724662485201510.3390/cancers7040904266944674695904 FloydDHZhangYDeyBKKefasBBreitHMarksKDuttaAHerold-MendeCSynowitzMGlassRNovel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9 and BimPLoS One9e96239201410.1371/journal.pone.0096239248058214013090 LiJHXiaoXZhangYNWangYMFengLMWuYMZhangYXMicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cellsGynecol Oncol120145151201110.1016/j.ygyno.2010.09.00920947150 YeYTangXSunZChenSUpregulated WDR26 serves as a scaffold to coordinate PI3K/AKT pathway-driven breast cancer cell growth, migration, and invasionOncotarget71785417869201610.18632/oncotarget.7439268953804951255 SafdariYKhaliliMEbrahimzadehMAYazdaniYFarajniaSNatural inhibitors of PI3K/AKT signaling in breast cancer: Emphasis on newly-discovered molecular mechanisms of actionPharmacol Res93110201510.1016/j.phrs.2014.12.00425533812 YakisichJSAzadNVenkatadriRKulkarniYWrightCKaushikVIyerAKFormation of tumorspheres with increased stemness without external mitogens in a lung cancer modelStem Cells Int20165603135201610.1155/2016/5603135268809694736427 SunYTuYHeLIJiCChengBOHigh mobility group box 1 regulates tumor metastasis in cutaneous squamous cell carcinoma via the PI3K/AKT and MAPK signaling pathwaysOncol Lett115962201626870167

Cell viability of different transfected groups. (A) Expression of miR-21 in the control, miR-21 overexpressing, mismatch siRNA and miR-21 siRNA groups. miR-21 was overexpressed by miR-21 transfection and effectively inhibited by miR-21 siRNA. (B) Cell viability results from the MTT assay of all groups. Error bars represent the mean ± standard deviation. *P<0.05 or **P<0.01 vs. control; #P<0.05 or ##P<0.01 vs. mismatch siRNA. miR, microRNA; siRNA, small interfering RNA.

Cellular apoptosis of different transfected groups. Cells overexpressing miR-21 exhibited a lower apoptotic rate. Inhibition of miR-21 was associated with increased apoptotic rate. Error bars represent the mean ± standard deviation. *P<0.05 vs. control; #P<0.05 vs. mismatch siRNA. miR, microRNA; siRNA, small interfering RNA; FL, fluorescence; LIN, lineage.

Phosphatidylinositol 3-kinase/Akt signaling pathway is involved in miR-21-mediated inhibition of cellular apoptosis. Western blotting results of apoptosis-associated proteins. p-, phosphorylated-; Akt, Rac-α serine/threonine protein kinase; Bcl-2, B-cell lymphoma 2; BAX, Bcl-2-associated X; miR, microRNA; siRNA, small interfering RNA.

Apoptotic index of transfected cells. miR-21 siRNA + Akt inhibitor cells exhibited decreased apoptosis compared with the miR-21 siRNA group. Error bars represent the mean ± standard deviation. *P<0.05 and #P<0.05, as indicated. miR, microRNA; siRNA, small interfering RNA; Akt, Rac-α serine/threonine protein kinase; FL, fluorescence; LIN, lineage.